Revolution Medicines, Inc. is 1.1x more valuable than BIOGEN INC. by market capitalization ($30.74 B vs $28.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RVMD | BIIB |
|---|---|---|
| Market cap | $30.74 B | $28.73 B |
| US-listed rank | #453 | #479 |
| Revenue (latest FY) | $0.00 | $9.89B |
| Net income (latest FY) | -$1.13B | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 782 | 2,690 |
Revolution Medicines, Inc. is 1.1x more valuable than BIOGEN INC. by market capitalization ($30.74 B vs $28.73 B).
In their latest fiscal years, Revolution Medicines, Inc. reported $0.00 in revenue while BIOGEN INC. reported $9.89B.
Full pages: Revolution Medicines, Inc. and BIOGEN INC., or browse the full rankings.